PRIMARY OPEN ANGLE GLAUCOMA (POAG)
Clinical trials for PRIMARY OPEN ANGLE GLAUCOMA (POAG) explained in plain language.
Never miss a new study
Get alerted when new PRIMARY OPEN ANGLE GLAUCOMA (POAG) trials appear
Sign up with your email to follow new studies for PRIMARY OPEN ANGLE GLAUCOMA (POAG), keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New Preservative-Free eye drop could match leading glaucoma treatment
Disease control Recruiting nowThis phase 3 trial tests whether a preservative-free version of bimatoprost eye drops works as well as the standard Lumigan drops for lowering eye pressure. About 600 adults with primary open-angle glaucoma or ocular hypertension in both eyes will receive either the new formulati…
Matched conditions: PRIMARY OPEN ANGLE GLAUCOMA (POAG)
Phase: PHASE3 • Sponsor: YS Life Science Co., Ltd. • Aim: Disease control
Last updated Jun 27, 2026 14:01 UTC
-
Gene therapy injection aims to lower eye pressure in glaucoma
Disease control Recruiting nowThis early study tests a new gene therapy called GVB-2001 for people with primary open-angle glaucoma. The treatment is given as an injection into the eye to help lower high pressure inside the eye. About 6 adults aged 18 to 75 with glaucoma for at least a year will take part. Th…
Matched conditions: PRIMARY OPEN ANGLE GLAUCOMA (POAG)
Phase: PHASE1, PHASE2 • Sponsor: IVIEW Therapeutics Inc. • Aim: Disease control
Last updated Jun 27, 2026 12:29 UTC
-
Glaucoma patients: could this supplement save your sight?
Disease control Recruiting nowThis study tests whether a daily supplement called BrudyGlauco (containing DHA and citicoline) can help protect eyesight in people with glaucoma. About 108 participants will take either the supplement or a placebo for 12 months. The goal is to see if it slows vision loss and impr…
Matched conditions: PRIMARY OPEN ANGLE GLAUCOMA (POAG)
Phase: NA • Sponsor: Institut Catala de Retina • Aim: Disease control
Last updated Jun 27, 2026 08:11 UTC
-
New eye drop aims to lower pressure in glaucoma patients
Disease control Recruiting nowThis Phase 3 trial tests a new eye drop called HUC3-637 in 206 adults with primary open-angle glaucoma or ocular hypertension. The goal is to see if it safely lowers eye pressure better than an existing active control. Participants will use the drops daily and have their eye pres…
Matched conditions: PRIMARY OPEN ANGLE GLAUCOMA (POAG)
Phase: PHASE3 • Sponsor: Huons Co., Ltd. • Aim: Disease control
Last updated Jun 27, 2026 08:10 UTC
-
Scientists dive into eye fluids to unlock glaucoma secrets
Knowledge-focused Recruiting nowThis study looks at fluid and tissue samples from the eyes of people with glaucoma and cataracts, and compares them to samples from people with cataracts only. The goal is to find chemical and protein patterns that could help doctors diagnose or track glaucoma better in the futur…
Matched conditions: PRIMARY OPEN ANGLE GLAUCOMA (POAG)
Phase: NA • Sponsor: Military Institute od Medicine National Research Institute • Aim: Knowledge-focused
Last updated Jun 27, 2026 11:00 UTC
-
Peeking inside the eye: ultrasound reveals how glaucoma surgery heals
Knowledge-focused Recruiting nowThis study uses a special ultrasound to take detailed pictures inside the eye after a type of glaucoma surgery. Researchers want to see how the eye heals and whether those images can predict how well the surgery controls eye pressure. Thirty adults with open-angle glaucoma who ha…
Matched conditions: PRIMARY OPEN ANGLE GLAUCOMA (POAG)
Sponsor: Minia University Hospital • Aim: Knowledge-focused
Last updated Jun 27, 2026 09:10 UTC